| scholarly article | Q13442814 |
| P2093 | author name string | Hui Li | |
| Kun Zhang | |||
| Li-Hong Liu | |||
| Jie Bu | |||
| Tao Xiao | |||
| Yurong Ouyang | |||
| Hanchong Zhang | |||
| Hong-Bin Guo | |||
| P2860 | cites work | Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection | Q21134914 |
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| Circulating microRNAs in cancer: origin, function and application | Q27013716 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| The diverse functions of microRNAs in animal development and disease | Q28266193 | ||
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
| Osteosarcoma: review of the various types with emphasis on recent advancements in imaging | Q30456669 | ||
| Primary malignant bone tumors--recent developments | Q33274167 | ||
| Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis | Q34089030 | ||
| Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis | Q34125617 | ||
| Chemotherapy-induced modification of microRNA expression in esophageal cancer. | Q34199320 | ||
| MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer | Q34231823 | ||
| Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. | Q34259569 | ||
| MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma | Q34263797 | ||
| Expression of microRNAs in basal cell carcinoma. | Q34271420 | ||
| Serum microRNAs as non-invasive biomarkers for cancer | Q34408233 | ||
| Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma | Q34441361 | ||
| Circulating microRNAs as specific biomarkers for breast cancer detection. | Q34542335 | ||
| MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma | Q34570975 | ||
| MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer | Q34621552 | ||
| Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status | Q34625392 | ||
| The molecular pathogenesis of osteosarcoma: a review | Q34629074 | ||
| Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). | Q34638253 | ||
| Deregulated expression of miR-106a predicts survival in human colon cancer patients | Q34784235 | ||
| microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells | Q34968346 | ||
| miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK | Q34980918 | ||
| Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. | Q35011389 | ||
| Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. | Q35017237 | ||
| Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | Q35623347 | ||
| miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. | Q35783986 | ||
| miRNA signatures associate with pathogenesis and progression of osteosarcoma | Q35894610 | ||
| MicroRNA Involvement in Osteosarcoma | Q35898407 | ||
| Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. | Q35922727 | ||
| Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer | Q36388236 | ||
| Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer | Q36546638 | ||
| Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
| Circulating microRNAs as potential new biomarkers for prostate cancer. | Q36896160 | ||
| MicroRNAs in disease and potential therapeutic applications | Q36945531 | ||
| Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma | Q36976141 | ||
| MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma | Q37368364 | ||
| miR-139-5p is a regulator of metastatic pathways in breast cancer | Q37448717 | ||
| miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma. | Q37548314 | ||
| MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. | Q39077654 | ||
| MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. | Q39090032 | ||
| miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells | Q39105277 | ||
| MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway | Q39120499 | ||
| MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1. | Q39121751 | ||
| MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. | Q39122905 | ||
| MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. | Q39172188 | ||
| miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma | Q39178990 | ||
| Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts | Q39242784 | ||
| miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. | Q39441445 | ||
| Prognostic implications of serum microRNA-21 in colorectal cancer. | Q43937592 | ||
| Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. | Q44434844 | ||
| The effect of local recurrence on survival in resected osteosarcoma | Q44584457 | ||
| Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma | Q44972673 | ||
| miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome | Q45021809 | ||
| MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. | Q45907786 | ||
| Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours. | Q52843051 | ||
| Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma | Q82251029 | ||
| MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer | Q86892940 | ||
| P433 | issue | 3 | |
| P921 | main subject | microRNA | Q310899 |
| biomarker | Q864574 | ||
| P304 | page(s) | 1662-1668 | |
| P577 | publication date | 2015-06-16 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma | |
| P478 | volume | 10 |
| Q46036353 | Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma. |
| Q89122043 | Circulating miR-215-5p and miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in Mexican population |
| Q90721521 | Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma |
| Q41673524 | Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases. |
| Q38734775 | Cross-sectional relations of whole-blood miRNA expression levels and hand grip strength in a community sample |
| Q61443284 | FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG |
| Q50892571 | MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4. |
| Q47449612 | MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis |
| Q26748881 | New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies |
| Q92642131 | Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies |
| Q92713862 | Signatures of circulating microRNA in four sarcoma subtypes |
| Q38810073 | Translating microRNAs into biomarkers: What is new for pediatric cancer? |
| Q38705618 | miR-22 promotes apoptosis of osteosarcoma cells via inducing cell cycle arrest |
| Q90634286 | miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b |
Search more.